MEDICAP BILBERRY
Natural health product licensed in Canada
- Licence holder
- Biowell Laboratories
- NPN or DIN-HM
- 80067929
- Status
- Active licence
- Licence date
- 23 March 2016
- Revision date
- 7 October 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vaccinium myrtillus Source : Fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 10,000 mg Potency : 36 Pour cent anthocyanosides | 500 milligramme | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Phosphate dicalcique, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
used in Herbal Medicine as an astringent to help relieve diarrhoea. Provides antioxidants for the maintenance of good health. Used in Herbal Medicine to help slow the progression of disorders of the eye, such as diabetic and hypertensive retinopathy, and macular degeneration. Used in Herbal Medicine to help relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For relief of diarrhoea and relief of mild inflammations of the mucous membranes of the mouth and/or throat: Consult a health care practitioner if symptoms persist or worsen. For slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI: Consult a health care practitioner if symptoms worsen.
Source
Official Health Canada record, licence 80067929
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.